Category Medicine and Healthcare
Press Release
Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans
Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groups Clinical findings reinforce preclinical data supporting recent FDA approval of 2025-2026 formula of Spikevax Read More
Press Release
President Trump Clears the Path for Medical Marijuana Reform - Now Will DEA's Terry Cole Act?
"By throwing out the DEA's Biden marijuana mess, President Trump opened the door for real medicine - MMJ's FDA cannabis trials for Huntington's and Multiple Sclerosis patients can't wait any longer." stated MMJ's CEO Duane Boise. Read More
Press Release
Federal Legal Marijuana? MMJ's Billion Dollar Trajectory: We're Not Selling Marijuana, We're Capturing a Market
MMJ International Holdings Is Betting on Medicine, Not Marijuana Is Pharmaceutical Grade Cannabis Aiming for the Next Blockbuster? Duane Boise, MMJ's CEO is banking on it. Backed by $10M+ in investment, vertically integrated cultivation and lab operations, and a patient-first mission, MMJ International Holdings is positioned to follow in the footsteps of Epidiolex and Marinol-cannabis derived drugs that now generate hundreds of millions annually. Read More
Press Release
MIRA Pharmaceuticals Shareholders Approve Acquisition of SKNY Pharmaceuticals, Advancing Next-Generation Oral Therapeutic for Obesity and Smoking Cessation
SKNY transaction strengthens MIRA pipeline with SKNY-1, a differentiated oral candidate that has demonstrated up to 30% weight loss and nicotine craving reversal in preclinical studies. Read More
Press Release
PharmaNest, NIH and VCU Launch Confirmatory Retrospective Outcome Study With 1,765 Patients to Advance AI-Driven Digital Pathology in MASLD
PharmaNest Inc. announced today a multi-institutional research collaboration with Virginia Commonwealth University (VCU) and the National Institutes of Health (NIH) to confirm the prognostic performance of artificial intelligence (AI) powered digital pathology biomarkers in metabolic dysfunction-associated steatotic liver disease (MASLD) in a retrospective cohort of 1,765 patients with MASH (NASH CRN DB2 Cohort) Read More
Press Release
Feds Move To Axe Key DEA Marijuana Rules Clearing the Way for MMJ's FDA Compliant HD and MS Trials
"Trump's Deregulatory Mandate Is Finally Driving DEA Marijuana Policy Reform," states Duane Boise, CEO of MMJ BioPharma Cultivation. Under President Trump's Executive Order 14192 ("Unleashing Prosperity Through Deregulation"), DOJ's notice eliminates several DEA proposals long cited as "in process". Read More
Press Release
Medical Care Technologies Inc. (OTC Pink:MDCE) Subsidiary Infinite Auctions Secures $2.54M Memorabilia Inventory, Reinforcing Growth and Supporting AI Healthcare Mission
With high-value assets including a LeBron James 2016 NBA Finals game worn jersey and rare Tom Brady 1/1 card, Infinite Auctions bolsters MDCE's balance sheet to accelerate development of its AI health platform. Read More
Press Release
Imagene AI and Sheba Medical Center Launch a Precision Oncology Intelligence Alliance to Scale Personalized Cancer Care
Strategic collaboration will integrate Sheba's real-world data with Imagene AI's Cross Modality Intelligence Engine to enable multimodal research, predictive models, and faster translation to care "Partnering with an innovative leader like Imagene AI strengthens our mission to transform Sheba into an AI-driven hospital and a global model of healthcare innovation" Read More
Press Release
Protagonist Announces Icotrokinra Application for Approval in Plaque Psoriasis Submitted to the European Medicines Agency
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing based on four Phase 3 studies that met all primary and co-primary endpoints. This unprecedented data package includes head-to-head superiority comparisons versus deucravacitinib, adolescent data, and evaluation of difficult to treat skin sites2,3,4,5,6 Submission underscores that icotrokinra has the potential to offer moderate-to-severe plaque psoriasis patients the combination of complete skin clearance and a favourable safety profile, relative to comparators, with the simplicity of a once-daily tablet. 2,3,4,5,6 Read More
Press Release
MDCE Subsidiaries Generate Over $1 Million in Revenue Before Close of Q3, Paving Way for Debt-Free Growth and AI Healthcare Advancements
Infinite Auctions' Blockbuster LeBron James Finals jersey sale and Real Game Used's authentication revenues strengthen MDCE's balance sheet and support AI-powered healthcare application development. Read More
Press Release
Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data
- Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients - - Gemini could potentially revolutionize the treatment of acute and chronic inflammatory disease - Data discussion webcast/conference call will be held at 8:30 am Eastern Time Read More
Press Release
KLAS Highlights Sublimation Health for Outstanding Healthcare Cloud Services
Sublimation Health has been recognized in the KLAS Emerging Company Spotlight Report, an independent evaluation based on direct provider feedback. Customers rated Sublimation Health among the very best in the industry, giving the company consistent A+ ratings that reflect its ability to deliver resilient environments, cost clarity, and meaningful cloud outcomes. Read More
Press Release
FDA Highlights Benzene Presence in Benzoyl Peroxide Acne Products - CLn Acne Cleanser Offers an Alternative
Following new safety concerns from the U.S. Food and Drug Administration (FDA) regarding benzoyl peroxide (BPO) acne products, CLn Skin Care is launching an education and awareness campaign to inform both physicians and consumers of safer alternatives for acne management. In its March 2024 safety communication, the FDA revealed that approximately 10% of benzoyl peroxide acne products tested showed elevated levels of benzene, a known human carcinogen.¹ Read More
Press Release
PillSafe Launches SAFE Investment Opportunity to Advance the First Wireless Smart Prescription Bottle Technology System
Launch timetable is now imminent for developers of a revolutionary system for medication management as they open an initial SAFE investment round and will fund final product development and market validation in compelling use-case. Read More
Press Release
Telomir Pharmaceuticals Announces New Cancer Data in Aggressive Human Prostate Cancer Cells Showing Telomir-1 Resets DNA Methylation to Reactivate CDKN2A, a Master Tumor Suppressor, Outperforming Rapamycin and Chemotherapy
New preclinical findings highlight Telomir-1's ability to reverse CDKN2A gene silencing by DNA methylation, reactivating this gene - often called the body's natural "cell cycle brake." These results build on prior STAT1 data, supporting Telomir-1's profile as a potential first-in-class broad-spectrum DNA methylation reset therapy. Read More
Press Release